In summary, CCT6A expression is upregulated in NSCLC tumor tissue compared with adjacent tissue; meanwhile, its high tumor expression correlates with LYN metastasis, increased TNM stage, abnormal CEA, and independently predicts poor DFS as well as OS in NSCLC patients. Here, CEACAM5 is linked to neoplasm.